EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins

Danielle Fehr iD, Van Hung Huynh-Tran iD, Laura Maintz iD, David Niederseer iD, Milad Ameri iD, Anita Dreher iD, Ck-Care Study Group, Cezmi A Akdis iD, Roger Lauener iD, Claudio Rhyner iD, Claudia Traidl-Hoffmann iD, Peter Schmid-Grendelmeier iD und 2 weitere

Allergy · 2025

DOI: 10.1111/all.16588 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Allergy, 2025. Verfasst von Danielle Fehr und 13 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Christine Kühne - Center for Allergy Research and Education, Christine Kühne – Center for Allergy Research and Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are conflicting data on a potential association between atopic dermatitis (AD) and cardiovascular diseases (CVD). The aim of this study was to further explore this connection and whether there are biomarkers indicating the risk for CVD in AD patients.

Methods

We included 677 AD patients and 79 nonatopic controls from an observational multicenter case–control study (ProRaD: Prospective longitudinal study investigating the remission phase in patients with atopic dermatitis and other allergy‐associated diseases). AD severity and atopic, metabolic, and cardiovascular conditions as well as risk factors were assessed. Serum samples were analyzed with targeted proteomics (cardiometabolics panel, Olink).

Results

We did not find an overall association between AD and CVD. However, AD patients without atopic comorbidities (pure AD) showed a significantly higher CVD prevalence than AD patients with atopic comorbidities (ADAC) (28.2% [37/131] vs. 14.7% [80/546], p < 0.001). Yet, this association could not be confirmed when controlling for cardiovascular risk factors. In pure AD, patients with CVD showed a more severe AD than those without CVD (median EASI [Eczema Area and Severity Index] 12.9 vs. 4.0, p < 0.001). In this subgroup of patients, EASI remained a significant predictor of CVD even in the adjusted model (adjusted odds ratio [aOR] = 1.05, p = 0.040). Forty serum cardiometabolic proteins were upregulated in AD patients compared with nonatopic controls. CC‐chemokine ligand 18 (CCL18) was upregulated in both AD ( p < 0.001) and CVD ( p < 0.001) and its increase correlated with AD severity.

Conclusions

Our study does not suggest an overall association between AD and CVD, but a more complex relation between the two conditions. Disease severity may be a risk factor for CVD in pure AD patients, but not in those with atopic comorbidities. CCL18 may be a biomarker for CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicCardiovascular DiseasesHumansMaleFemaleBiomarkersMiddle AgedCase-Control StudiesAdultComorbidityProteomicsProspective StudiesRisk FactorsLongitudinal StudiesSeverity of Illness IndexAged

Stichwörter der Autor:innen

atopic dermatitisatopycardiovascular diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
  • Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.
  • Department of Cardiology, Hochgebirgsklinik Davos, Davos, Switzerland.
  • Center of Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Danielle Fehr, Van Hung Huynh-Tran, Laura Maintz, David Niederseer, Milad Ameri, Anita Dreher, Cezmi A Akdis, Roger Lauener, Claudio Rhyner, Claudia Traidl-Hoffmann, Peter Schmid-Grendelmeier, Thomas Bieber, Marie-Charlotte Brüggen

Förderung

  • Christine Kühne - Center for Allergy Research and Education
  • Christine Kühne – Center for Allergy Research and Education

Zitieren

APA

Fehr, D., Huynh-Tran, V. H., Maintz, L., Niederseer, D., Ameri, M., Dreher, A., Study Group, C. C., Akdis, C. A., Lauener, R., Rhyner, C., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Bieber, T., & Brüggen, M. C. (2025). Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins. Allergy. https://doi.org/10.1111/all.16588

Vancouver

Fehr D, Huynh-Tran VH, Maintz L, Niederseer D, Ameri M, Dreher A, et al. Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins. Allergy. 2025. doi:10.1111/all.16588

BibTeX
@article{Fehr2025,
  author = {Fehr, Danielle and Huynh-Tran, Van Hung and Maintz, Laura and Niederseer, David and Ameri, Milad and Dreher, Anita and Study Group, Ck-Care and Akdis, Cezmi A and Lauener, Roger and Rhyner, Claudio and Traidl-Hoffmann, Claudia and Schmid-Grendelmeier, Peter and Bieber, Thomas and Brüggen, Marie-Charlotte},
  title = {Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16588}
}
Kostenlos starten →